Evidence map›Paper›PMID 42532507›Full record

ArticleStatistics in medicine2026

A Comparison of Testing Procedures for Detecting Short- and Long-Term Effects of Biomarkers for Cancer Screening.

Siddharth Roy, Paul S Albert, Anindya Roy, Danping Liu

Abstract readComparative Study
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Siddharth RoyBiostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.ORCID https://orcid.org/0009-0002-5030-008X
Paul S AlbertBiostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Anindya RoyDepartment of Mathematics and Statistics, University of Maryland Baltimore County, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-6361-8295
Danping LiuBiostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.

Funding

Intramural Research Program of the National Institutes of Health (NIH)
6 · The paper itself

Abstract

Longitudinal cancer biomarker studies aim to identify markers useful for long-term associations with cancer risk and early detection of cancer diagnosis. Early detection biomarkers show acute associations, meaning longitudinal trajectory changes sharply just before diagnosis, while long-term risk prediction biomarkers are often represented as changes in slopes or levels. We compare three common approaches to identify longitudinal biomarkers associated with survival outcomes: joint models, conditional models, and Cox models with time-varying covariates. Each of the three methods uses a different modeling framework for the joint density of the biomarkers and survival time. Thus, they have distinct advantages and disadvantages for detecting acute and long-term associations. We investigate the power and Type I error rates for the three approaches under different data-generating settings with regular yearly visits and moderate measurement error to evaluate robustness to assumptions and the power gain from using test statistics that match the data's association structure. The Cox model controlled Type I errors rates and maintained high power to detect associations across the scenarios considered. The conditional and joint models had inflated Type I errors under longitudinal model misspecification and only outperformed the Cox model for power when the correct model is used. However, only the conditional model can effectively disentangle the acute and long-term effects. The Cox model's convex likelihood also provides the fastest convergence. We apply all three approaches to a study of the association between CA-125 and ovarian cancer in the National Cancer Institute Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. The results follow similar patterns to those of our simulations.

Indexed as

Biomarkers, TumorEarly Detection of CancerModels, StatisticalNeoplasmsComputer SimulationFemaleHumansLongitudinal StudiesMaleProportional Hazards ModelsSurvival AnalysisBiomarkers, Tumorconditional modeljoint modellongitudinal biomarkerssurvival analysis

Identifiers

PMID42532507
PMCPMC13423587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.